83 related articles for article (PubMed ID: 33841707)
1. The diagnostic value of miR-145 and miR-205 in patients with cervical cancer.
Yu F; Liu J; Dong W; Xie J; Zhao X
Am J Transl Res; 2021; 13(3):1825-1832. PubMed ID: 33841707
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of miR-153 and miR-203 in patients with cervical cancer and their correlation with human papillomavirus infection.
Wang Y; Xu B; Shen X; Sun L
Am J Transl Res; 2021; 13(8):9736-9742. PubMed ID: 34540103
[TBL] [Abstract][Full Text] [Related]
3. Serum miR-3142 could be Used as a Potential Biomarker to Screen Cervical Cancer Patients from Healthy Controls.
Luo Q; Wang H; Li J
Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969093
[TBL] [Abstract][Full Text] [Related]
4. Suppression of miR-93-5p inhibits high-risk HPV-positive cervical cancer progression via targeting of BTG3.
Li J; Chu ZP; Han H; Zhang Y; Tian F; Zhang JQ; Huang XH
Hum Cell; 2019 Apr; 32(2):160-171. PubMed ID: 30689165
[TBL] [Abstract][Full Text] [Related]
5. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer.
Zhao S; Yao D; Chen J; Ding N
Genet Test Mol Biomarkers; 2013 Aug; 17(8):631-6. PubMed ID: 23819812
[TBL] [Abstract][Full Text] [Related]
6. miRNA Expression Profiles of HPV-Infected Patients with Cervical Cancer in the Uyghur Population in China.
Gao D; Zhang Y; Zhu M; Liu S; Wang X
PLoS One; 2016; 11(10):e0164701. PubMed ID: 27764149
[TBL] [Abstract][Full Text] [Related]
7. Serum and tissue miRNAs: potential biomarkers for the diagnosis of cervical cancer.
Farzanehpour M; Mozhgani SH; Jalilvand S; Faghihloo E; Akhavan S; Salimi V; Azad TM
Virol J; 2019 Oct; 16(1):116. PubMed ID: 31590680
[TBL] [Abstract][Full Text] [Related]
8. MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer.
Park S; Eom K; Kim J; Bang H; Wang HY; Ahn S; Kim G; Jang H; Kim S; Lee D; Park KH; Lee H
BMC Cancer; 2017 Sep; 17(1):658. PubMed ID: 28934937
[TBL] [Abstract][Full Text] [Related]
9. Serum miRNA Combined With Transvaginal Color Doppler Ultrasound Diagnosis Clinical Research on Cervical Cancer.
Wang Y; Yang J; Wang Y
J Ultrasound Med; 2024 Apr; 43(4):791-798. PubMed ID: 38269478
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of miR-3653 is Associated with HPV Infection and Serves as a Biomarker in Patients with Cervical Cancer.
Cui H; Zhang B; Ruan M; Fang C; Li N; Sun X; Qi J; Zuo R; Zhang S; Rong J
Int J Womens Health; 2022; 14():1037-1045. PubMed ID: 35966402
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic validity of human papillomavirus E6/E7 mRNA test in cervical cytological samples.
Liu TY; Xie R; Luo L; Reilly KH; He C; Lin YZ; Chen G; Zheng XW; Zhang LL; Wang HB
J Virol Methods; 2014 Feb; 196():120-5. PubMed ID: 24216236
[TBL] [Abstract][Full Text] [Related]
12. Study on serum miR-182 as a marker for diagnosis and prognosis of cervical cancer.
Gao F; Wang Y; Li H; Yin J
Technol Health Care; 2024 May; ():. PubMed ID: 38848201
[TBL] [Abstract][Full Text] [Related]
13. MiR-34a Inhibits Viability and Invasion of Human Papillomavirus-Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin.
Geng D; Song X; Ning F; Song Q; Yin H
Int J Gynecol Cancer; 2015 May; 25(4):707-13. PubMed ID: 25675046
[TBL] [Abstract][Full Text] [Related]
14. Values of miR-34a and miR-218 expression in the diagnosis of cervical cancer and the prediction of prognosis.
Wang P; Zhai G; Bai Y
Oncol Lett; 2018 Mar; 15(3):3580-3585. PubMed ID: 29456728
[TBL] [Abstract][Full Text] [Related]
15. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
[TBL] [Abstract][Full Text] [Related]
16. Histological and cytological evidence of viral infection and human papillomavirus type 16 DNA sequences in cervical intraepithelial neoplasia and normal tissue in the west of Scotland: evaluation of treatment policy.
Murdoch JB; Cassidy LJ; Fletcher K; Cordiner JW; Macnab JC
Br Med J (Clin Res Ed); 1988 Feb; 296(6619):381-5. PubMed ID: 2830935
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples.
Jentschke M; Soergel P; Hillemanns P
J Virol Methods; 2013 Oct; 193(1):131-4. PubMed ID: 23707925
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of 3D-CPA, HR-HPV, and TCT joint detection on cervical disease screening.
Liang H; Fu M; Zhou J; Song L
Oncol Lett; 2016 Aug; 12(2):887-892. PubMed ID: 27446364
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women.
Orangi E; Motovali-Bashi M
Gene; 2019 Mar; 687():272-279. PubMed ID: 30468908
[TBL] [Abstract][Full Text] [Related]
20. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.
Xia YF; Pei GH; Wang N; Che YC; Yu FS; Yin FF; Liu HX; Luo B; Wang YK
Virol J; 2017 Feb; 14(1):20. PubMed ID: 28160779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
